A UV-sensitive syndrome patient with a specific CSA
mutation reveals separable roles for CSA in response
to UV and oxidative DNA damage
Tiziana Nardoa, Roberta Onedaa, Graciela Spivakb, Bruno Vaza, Laurent Mortierc, Pierre Thomasc, Donata Oriolia,
Vincent Laugeld, Anne Staryd, Philip C. Hanawaltb,1, Alain Sarasind,1, and Miria Stefaninia,1
aIstituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche, via Abbiategrasso 207, 27100 Pavia, Italy;bDepartment of Biology, Stanford University,
Stanford, CA 94305;cClinique de Dermatologie, Centre Hospitalier Re ´gional Universitaire de Lille, 59037 Lille, France; anddLaboratory of Genomes and
Cancer, Centre National de la Recherche Scientifique FRE2939, Institut Gustave Roussy, 94805 Villejuif, France
Contributed by Philip C. Hanawalt, February 25, 2009 (sent for review March 15, 2008)
UV-sensitive syndrome (UVSS) is a recently-identified autosomal
recessive disorder characterized by mild cutaneous symptoms and
defective transcription-coupled repair (TC-NER), the subpathway
of nucleotide excision repair (NER) that rapidly removes damage
that can block progression of the transcription machinery in
actively-transcribed regions of DNA. Cockayne syndrome (CS) is
of CS include neurological/developmental abnormalities and pre-
in individuals with mutations in CSB or in a still-unidentified gene.
We report the identification of a UVSS patient (UVSS1VI) with a
novel mutation in the CSA gene (p.trp361cys) that confers hyper-
are notably cytotoxic in cells from CS patients. The defect in
UVSS1VI cells is corrected by expression of the WT CSA gene.
Expression of the p.trp361cys-mutated CSA cDNA increases the
resistance of cells from a CS-A patient to oxidative stress, but does
not correct their UV hypersensitivity. These findings imply that
some mutations in the CSA gene may interfere with the TC-NER-
dependent removal of UV-induced damage without affecting its
role in the oxidative stress response. The differential sensitivity
toward oxidative stress might explain the difference between the
range and severity of symptoms in CS and the mild manifestations
in UVsS patients that are limited to skin photosensitivity without
precocious aging or neurodegeneration.
Cockayne syndrome ? DNA repair ? transcription-coupled repair ?
lesions, including UV photoproducts, which result in ‘‘bulky’’
local distortions of the DNA helix. NER operates through 2
subpathways in the early stages of damage recognition, depend-
ing on whether the damage is located anywhere throughout the
genome [global genome repair (GG-NER)] or in an actively-
transcribed gene [transcription-coupled repair (TC-NER)].
GG-NER begins with recognition of the damage by the XPC-
RAD23B-cen2 complex, aided in some cases by the UV-
damaged DNA binding activity (UV-DDB) that includes the
subunits DDB1 and DDB2/XPE. The mechanisms for TC-NER
are not completely understood; a current model postulates that
the pathway is initiated by the arrest of RNA polymerase II at
a lesion on the transcribed strand of an active gene, in a process
that requires several factors including the CSA, CSB, and XAB2
are followed by a common pathway involving the unwinding of
the damaged DNA, dual incisions in the damaged strand,
removal of the damage-containing oligonucleotide, repair syn-
thesis in the resulting gap, and ligation of the repair patch to the
contiguous parental DNA strand. These steps require the coor-
ucleotide excision repair (NER) is a versatile DNA repair
system that removes a wide range of structurally-unrelated
dinated action of several factors and complexes, including the
repair/transcription complex TFIIH, and the repair factors XPA,
XPG, and ERCC1-XPF in addition to those required for repair
replication and ligation.
Defects in NER are associated with 3 major autosomal
recessive disorders, namely xeroderma pigmentosum (XP),
Cockayne syndrome (CS), and trichothiodystrophy (TTD). At
the clinical level XP is characterized by a highly increased
incidence of tumors in sun-exposed areas of the skin (reviewed
in ref. 3). In contrast, CS and TTD are cancer-free disorders
characterized by developmental and neurological abnormalities
and premature aging, associated in TTD with typical hair
abnormalities (reviewed in ref. 4). Seven NER-deficient comple-
mentation groups have been identified in XP (designated XP-A
to XP-G). The XP-C and XP-E groups are specifically defective
in GG-NER, whereas the remaining groups are defective in both
NER subpathways. The 2 genes identified so far as responsible
for the NER-defective form of CS (CSA and CSB) are specifi-
cally involved in TC-NER. In addition, rare cases have been
described showing a complex pathological phenotype with com-
bined symptoms of XP and CS (XP/CS) that have been associ-
ated with mutations in the XPB, XPD, or XPG genes (4). An
eighth complementation group, the XP variant, is caused by
defective translesion DNA synthesis (3).
NER defects have been reported in association with another
disorder, designated UV-sensitive syndrome (UVSS). Initially
described in 1994 by Itoh et al. (5), this condition currently
comprises 1 Israeli (UVSTA24 or TA-24) and 5 Japanese (Kps2,
Kps3, UVS1KO, XP24KO, and CS3AM) individuals. The pa-
tients exhibit photosensitivity and mild skin abnormalities; their
growth, mental development, and life span are normal, and no
skin or internal cancers have been reported to date. However, it
must be noted that the oldest known UVSS patient is ?40 years
old. At the cellular level, UVSS and CS cells exhibit similar
responses to UV irradiation: increased sensitivity to the cyto-
toxic effects of UV light, reduced recovery of RNA synthesis
(RRS) after UV irradiation, and normal capability to perform
UV-induced DNA repair synthesis (5, 6). Like CS cells, UVSS
cells show normal GG-NER and are deficient in TC-NER of
UV-induced cyclobutane pyrimidine dimers (CPD) (7).
Author contributions: G.S., A. Sarasin, and M.S. designed research; T.N., R.O., G.S., B.V.,
D.O., V.L., and A. Stary performed research; L.M. and P.T. contributed new reagents/
analytic tools; T.N., G.S., P.C.H., A. Sarasin, and M.S. analyzed data; and T.N., G.S., P.C.H.,
A. Sarasin, and M.S. wrote the paper.
The authors declare no conflict of interest.
Freely available online through the PNAS open access option.
1To whom correspondence may be addressed. E-mail: firstname.lastname@example.org, sarasin@
igr.fr, or email@example.com.
This article contains supporting information online at www.pnas.org/cgi/content/full/
April 14, 2009 ?
vol. 106 ?
no. 15 ?
Two complementation groups have been identified among
UVSS patients, defined by mutations in an as-yet-unidentified
gene in 4 cases and in the CSB gene in 2 individuals (reviewed
in ref. 8). In the latter cases, the mutation results in a severely
truncated protein; however, no CSB protein was detected by
Western blot analysis, and it has been proposed that the total
absence of the CSB protein may be less deleterious than the
truncated or abnormal counterparts found in CS-B patients (9).
However, this hypothesis is not supported by recent investiga-
tions on 2 severely affected CS patients with undetectable levels
of CSB protein and mRNA (10). Moreover, a mild form of CS
with late onset of symptoms has been described in a 47-year-old
individual with a mutation that results in a stop codon at amino
acid position 82. No CSB polypeptide could be detected in
extracts from this individual’s cells (11), a situation reminiscent
of that described by Horibata et al. (9), mentioned above. They
raised the possibility that UVSS patients with mutations that
result in very short, undetectable CSB protein might develop
CS-like symptoms as they age (11).
We report here the description, genetic analysis, and cellular
characteristics of a recently-identified UVSS patient (UVSS1VI)
with a novel mutation in the CSA gene; this French patient may
represent a third complementation group of UVSS. We show
that UVSS1VI cells do not display the increased cellular sensi-
tivity to oxidative stress typical of CS-A and CS-B fibroblasts.
Furthermore, we demonstrate that the ectopic expression of the
CSA gene cloned from UVSS1VI does not restore the altered
response to UV of CS-A cells, but it does increase their
resistance to oxidative stress. These findings support the hypoth-
esis that the striking differences between the pathological phe-
notypes of CS and UVSS are caused by defective processing of
oxidative DNA damage in CS but not in UVSS patients.
Description of the UVSS1VI Patient. The patient UVSS1VI, born in
1994, is the fourth child of healthy parents, who claimed the
absence of consanguinity but were born in the same region of
France; she has 3 healthy brothers. She presented sun sensitivity
at the age of 4 months with easy sun burning and erythema. She
has been monitored by the Dermatology Department of the
University Hospital of Lille for extreme sun sensitivity since she
was 8 years old. She presents numerous freckles on her face and
exposed areas of the neck but she has no history or evidence of
cutaneous tumors (Fig. 1); she wears sun protection when
outdoors. She is now 15 years old, her school performance is
normal, and she has not exhibited any developmental problems.
Results from all recent neurological tests, which included MRI
of the brain and audiogram, have been within normal ranges;
computed tomography (CT) brain scans or nerve conduction
detailed ophthalmologic examinations, yielded normal results.
Routine laboratory tests showed no abnormalities except hyper-
cholesterolemia at 2.4 g/dL. Blood levels of protoporphyrin and
coproporphyrin were all within the normal limits, thus excluding
the possibility that sun sensitivity could be related to high levels
of porphyrin derivatives.
Cellular Response to UV. UVSS1VI primary fibroblasts exhibited
normal capacity to perform UV-induced DNA repair synthesis
(Fig. 2A), partially reduced RRS (Fig. 2B), and hypersensitivity
to the lethal effects of UV (Fig. 2C). Caffeine had no further
effect on UV sensitivity (Fig. S1), indicating normal capacity to
carry out translesion DNA synthesis past UV-induced CPD, thus
excluding the variant form of XP (12). The cell cycle in unirra-
diated UVSS1VI cells was similar to that in normal and CS-B
cells, whereas a major block in G1/S was detected after UV
irradiation (Fig. 2D). The blockage in early S phase was com-
severe, as indicated by the very low number of cells in S phase
compared with those in G1(Fig. 2E).
The overall results from DNA repair investigations in
UVSS1VI indicated defective capacity to repair UV-induced
damage on the transcribed strand of active genes (i.e., TC-NER),
but normal ability to remove lesions from the overall genome
(i.e., GG-NER) and carry out translesion DNA synthesis, by-
passing pyrimidine dimers on damaged DNA. Thus, the UV-
induced cellular response of patient UVSS1VI was similar to that
typically observed in CS-A and CS-B fibroblasts, although the
alterations in RRS and survival were less severe than those
commonly observed in CS fibroblasts at lower UV doses.
Characterization of the Gene Responsible for the NER Defect in
UVSS1VI. Genetic analysis of the DNA repair defect in UVSS1VI
cells was carried out by evaluating the RRS after UV in classical
complementation tests based on somatic cell hybridization (Fig.
3A). RNA synthesis levels in the heterodikaryons obtained after
fusion of UVSS1VI cells with cells from CS-B patient CS1PV or
UVSS patient TA24 were higher than those in the corresponding
homodikaryons, indicating the presence of different genetic
defects in the fusion partners. Conversely, fusions with CS-A
cells from patient CS6PV did not result in increased RNA
synthesis levels in the heterodikaryons compared with those in
the homodikaryons. These results indicate that the activity of the
CSA protein is impaired in UVSS1VI cells.
To directly confirm that the partial DNA repair deficiency in
UVSS1VI was caused by mutations in the CSA gene, we mea-
sured the RRS after UV irradiation in primary fibroblasts
transiently transfected with a construct expressing the normal
CSA protein tagged with EGFP (Fig. 3 B and C). A substantial
increase in the RRS level was observed in cells exhibiting nuclear
accumulation of the green fluorescent signal of the CSA chi-
mera, compared with that in the nontransfected cells (Fig. 3B).
In UVSS1VI fibroblasts expressing the EGFP-CSA fusion pro-
tein, the mean number of grains per nucleus increased from
29.5 ? 1.5 to 50.1 ? 3.0 grains per nucleus, with ?70% of cells
showing RRS levels in the normal range (Fig. 3C). The lack of
restoration to normal levels of RRS in all of the transfected cells
is not unexpected in assays for correction of DNA repair defects
after microinjection or transfection of the WT gene (13, 14); it
can probably be attributed to failure of the ectopic protein to be
expressed under the optimal physiological conditions necessary
to fully complement the repair defect in all of the cells. Overall,
tumors have been observed to date.
Patient UVSS1VI is shown at age 8 (A and B) and age 13 (C and D)
www.pnas.org?cgi?doi?10.1073?pnas.0902113106Nardo et al.
these results point to CSA as the gene responsible for the UV
hypersensitivity in patient UVSS1VI.
Sequencing the CSA Gene.CompletesequencingoftheCSAcDNA
in UVSS1VI cells revealed the presence, in the entire amplified
population, of a G to T transversion at position 1083
(c.1083G?T), resulting in a trp361cys substitution (Fig. S2A).
No other mutations were observed, suggesting that this alter-
ation is responsible for the pathological phenotype of patient
UVSS1VI. Sequencing of the genomic DNA confirmed that the
patient was homozygous for this mutation (Fig. S2B), whereas
the mother was heterozygous for the same mutation (Fig. S2C).
Paternal material was not available. Therefore, patient
UVSS1VI is either homozygous or a functional hemizygous for
Effect of Expression of the CSA Gene Containing the 1083G>T Muta-
tion on DNA Repair. To directly confirm that the mutation found
to UV, we analyzed the RRS after UV irradiation in primary
normal and CS-A fibroblasts transiently transfected with a
construct expressing the trp361cys mutated CSA protein. No
effect was observed in the basal levels of RNA synthesis, whereas
both normal and CS-A fibroblasts failed to recover normal RNA
synthesis levels at late times after UV irradiation, indicating that
the trp361cys change results in defective function of the CSA
gene (Fig. 3D).
Cellular Sensitivity to Oxidative Stress in UVSS1VI Cells. Primary
hypersensitive to oxidants, and several lines of evidence indicate
that the CS proteins are involved in the repair of biologically-
diverse oxidative DNA lesions (ref. 15 and references therein).
Comparative evaluation of the response to potassium bromate,
a specific inducer of oxidative damage, showed that the cellular
sensitivity of UVSS1VI was similar to that of UVSS patient Kps3
and approached that of normal primary fibroblasts, whereas
CS-A and CS-B cells were characterized by a 2-fold increase in
sensitivity (Fig. 4A).
In addition, treatment of SV40-transformed derivatives of
UVSS1VI, CS3BE (CS-A), Kps3 (UVSS), and WT fibroblasts
with menadione, a form of vitamin K that induces reactive
oxygen species, resulted in a significant reduction in the clono-
genic survival of CS3BE cells, whereas UVSS1VI cells exhibited
survival similar to that of WT and UVSS Kps3 cells (Fig. 4B).
The effect of the mutated CSA trp361cys protein on responses
to DNA-damaging agents was further investigated by analyzing
the sensitivity to UV and menadione in isogenic cell lines
isolated from SV40-transformed CS3BE (CS-A) cells, which had
been stably transfected with a construct expressing either the
normal or the mutated (trp361cys) CSA protein tagged with
EGFP. The expression of WT CSA was associated with in-
creased survival levels after both treatments (Fig. 4 C and D). In
contrast, CS3BE cells ectopically expressing the CSAtrp361cys
protein were still sensitive to UV (Fig. 4C), whereas their
sensitivity to menadione was intermediate between those of
the isogenic cell lines stably expressing either WT CSA or
EGFP alone (Fig. 4D); as mentioned above, partial comple-
mentation is not unusual when expressing ectopic genes.
Overall, these findings indicate that the trp361cys change in
UV dose, J/m
5 10 205 10 20
UV dose, J/m
UV dose, J/m2
% 3H-TdR incorporation (cpm)
% ratio S/G1
UV dose, J/m
CS177VI UV S1VI
(XP-C) (dotted lines), and CS177VI and CS1PV (CS-B) (dashed lines). (A) UV-induced DNA repair synthesis (UDS) expressed as mean number of autoradiographic
grains/nucleus. Bars indicate the SE. (B) RRS 24 h after UV irradiation. The mean numbers of autoradiographic grains per nucleus in irradiated samples are
expressed as percentages of those in unirradiated cells. (C) Sensitivity to the lethal effects of UV light in proliferating fibroblasts labeled with3H-thymidine 48 h
after irradiation. Incorporation values in irradiated samples are expressed as percentages of those in unirradiated cells. The values in B and C were calculated
from at least 2 independent experiments with SE ?10% in all cases. (D) Cell cycle analysis by fluorescence-activated cell sorter (FACS) of fibroblasts from patient
UVSS1VI, normal donor C405VI, and CS-B patient CS177VI. Dot plots of exponentially growing fibroblasts 24 h after exposure to 0 or 10 J/m2of UV. Cells were
at the indicated UV doses.
Response to UV irradiation. Fibroblast strains were from 2 normal donors (C3PV and C405VI; ?) or patients UVSS1VI (F), XP11PV (XP-A) and XP202VI
Nardo et al.PNAS ?
April 14, 2009 ?
vol. 106 ?
no. 15 ?
the CSA protein hampers the removal of UV-induced DNA
lesions, while it does not substantially affect the removal of
cytotoxic oxidative DNA lesions.
gene that is associated with the mild clinical outcome diagnostic
for UVSS. This mutation, which had not been described previ-
ously to our knowledge, is predicted to cause a trp361cys
substitution. Mutational patterns in the 20 CS-A patients re-
ported in the literature (16–23) indicate that most of the
mutations result in severely-truncated polypeptides because of
stop codons, frameshifts, splice abnormalities or deletions (Fig.
5). Missense mutations resulting in the changes gln106pro,
tyr204lys, and ala205pro have been found in the heterozygous
state in single patients or affected members from the same
family, whereas the asp266gly substitution was observed in
the homozygous state in a pair of Brazilian siblings (16). Despite
the paucity of clinical data and DNA repair investigations, the
clinical outcome and the cellular features of these cases do not
differ from those typically reported in other CS patients with
severe inactivating mutations in CSA.
The mutation found in patient UVSS1VI is predicted to cause
a substitution of the next to last amino acid within the last
putative WD (W ? tryptophane, D ? aspartic acid) repeat of the
CSA protein. According to its primary sequence, CSA contains
5 WD repeats (18); 2 additional WD repeats (namely, WD3 and
WD6 in Fig. 5) have been predicted by sequence alignment with
structural templates by using the COBLATH method (24). WD
repeats are structural motifs capable of forming ?-sheets. As a
common functional theme, WD repeats form stable platforms
coordinating sequential and/or simultaneous interactions involv-
ing several sets of proteins. Accordingly, it has been shown that
CSA, through an interaction with DDB1, is integrated into a
multisubunit complex, designated the CSA core complex, which
displays E3-ubiquitin ligase activity. This activity is silenced
immediately after UV irradiation by the rapid association of the
CSA core complex with the COP9/signalosome (CSN), a protein
complex with ubiquitin isopeptidase activity (25). By a mecha-
nism dependent on CSB, TFIIH, chromatin structure, and
transcription elongation (26), the CSA core/CSN complex trans-
locates to the nuclear matrix where it colocalizes with the
hyperphosphorylated form of RNA polymerase II engaged in
transcription elongation (27). In cooperation with CSB, CSA
then participates in recruitment of chromatin remodeling and
repair factors to the arrested RNA polymerase II (28, 29). It has
been suggested that once the repair complex has assembled the
RNA polymerase II might be released, whereas CSB probably
helps reposition the repair complex (30). The CSA-associated
ubiquitin ligase activity, silenced by CSN at the beginning of the
0 20 40 60 80 100120
0 20 40 60 80 100120
020 40 60 80 100120
mentation and response to UV of normal and CS-A cells expressing the
EGFP-CSAtrp361cys fusion protein. (A) Complementation analysis in het-
erodikaryons obtained by fusion of UVSS1VI fibroblasts with cells representa-
tive of different excision repair-deficient groups (CS-A, CS6PV; CS-B, CS1PV;
UVSS, TA24). The partners in each fusion were labeled with latex beads of
different sizes, and the RRS 24 h after UV was analyzed 73 h after fusion. The
columns indicate the mean number of autoradiographic grains per nucleus in
heterodikaryons (dotted column). The bars indicate SE. The horizontal lines
indicate the grain number per nucleus in the corresponding unirradiated
samples analyzed in parallel. (B) RRS after UV irradiation in UVSS1VI primary
fibroblasts after transfection with the plasmid pEGFP-CSA. Nuclear accumu-
of autoradiographic grains, i.e., in the RRS levels, compared with nontrans-
fected cells (Left). (C) RRS after UV irradiation in C3PV, UVSS1VI, and UVSS1VI
expressing the EGFP-CSA fusion protein. The frequency distributions of nuclei
with different grain numbers and the mean values of RRS ? SE are shown. (D)
after transfection with the plasmid pEGFP-CSAtrp361cys. The columns indi-
cate the mean number of autoradiographic grains per nucleus in cells before
(unirradiated: white columns; irradiated: shaded columns) and after transfec-
tion with the plasmid pEGFP-CSAtrp361cys (unirradiated: black columns; ir-
radiated: dotted columns). The bars indicate SE.
Genetic analysis of the repair defect in patient UVSS1VI by comple-
UV dose, J/m2
primary fibroblasts from patient UVSS1VI (F), normal donor C3PV (?), UVSS
patient Kps3 (dotted line, ‚), and 2 CS patients (dashed lines; CS7PV: CS-A, E;
CS1AN: CS-B, ‚) to KBrO3treatment. Survival values in treated samples are
expressed as percentages of those in untreated cells. The reported values are
the mean of at least 2 independent experiments. The bars indicate SE. (B)
Response of SV40-transformed fibroblasts from patient UVSS1VI (F), normal
donor C405VI (?), CS-A patient CS3BE (E), and UVSS patient Kps3 (‚) to
menadione treatment. Clonogenic survival is expressed as percentage of that
expressing WT CSA (F), the mutated CSAtrp361cys protein (E), or GFP alone
values are the mean of at least 3 independent experiments.
Sensitivity to the lethal effects of oxidative stress. (A) Response of
www.pnas.org?cgi?doi?10.1073?pnas.0902113106Nardo et al.
repair process, becomes active at later stages and degrades CSB,
a key event for postrepair transcription recovery (ref. 31 and
reviewed in ref. 1).
Evidence that the CSA protein has additional functions be-
yond its role in TC-NER has been provided by showing that
CS-A primary skin cells, similar to CS-B cells, are hypersensitive
to the lethal effects of oxidizing agents (15). The involvement of
CS proteins in the removal of oxidative damage has been invoked
to explain the neurological and aging features typical of CS, which
notion has been supported by several independent observations
(reviewed in refs. 32 and 33) that include a recent study of eye
pathology in CS mouse models, implicating accumulation of en-
dogenous oxidative DNA lesions in the retina in pigmentary
retinopathy, a feature of CS-specific premature aging (34).
It is intriguing that the patient reported here, despite being
mutated in the CSA gene, exhibits the mild phenotype and
normal cellular sensitivity to oxidative stress typical of UVSS.
This observation suggests a causal contribution of unrepaired
oxidative damage to the aging and neurological degeneration at
the organismal level typical of CS. Furthermore, it implies that
the substitution trp361cys, resulting from the CSA mutation
detected in UVSS1VI, affects the function of CSA in UV-
induced TC-NER but does not interfere substantially with the
role of CSA in the removal of cytotoxic oxidative DNA lesions.
This finding has at least 2 relevant implications. First, the
trp361cys change does not disrupt or strongly destabilize the
overall structure of the CSA protein, events that would result in
the complete loss of all CSA functions. Second, the CSA
interactions implicated in the removal of cytotoxic oxidative
DNA lesions do not completely overlap those relevant for
Regions/sites of the CSA protein relevant for its multiple
interactions have not yet been fully elucidated. Nevertheless,
it has been shown that the ala205pro change found in CS
patient AG07075 (17), and the changes lys174ala and
arg217ala generated in the laboratory, abolish binding of CSA
to DDB1 (35). Residue 361 is located in the C-terminal region
of the protein and, as already mentioned, resides within the last
putative WD repeat. The codon mutated in UVSS1VI encodes
cysteine, an amino acid frequently present in ?-sheets, al-
though it has never been found next to the last amino acid (i.e.,
in the fifth position of the third strand) of the WD repeat in a
nonredundant set of 776 WD repeats found in 123 WD-repeat
proteins in SWISS-PROT/TrEMBL) (http://bmerc-www.bu.edu/
There is another activity whose alteration interferes with the
removal of UV-induced DNA damage by TC-NER without
affecting the cellular sensitivity toward oxidative agents (36).
This function is impaired in UVSS patients Kps2, Kps3, and
TA24, who belong to the UVSS complementation group whose
underlying gene has not yet been identified (reviewed in ref.
8). Thus, investigations on UVSS patients, despite the rarity of
this disorder, indicate that defects in TC-NER alone cause
mild cutaneous alterations and provide further evidence that
the additional features present in CS patients, namely preco-
cious aging and deficiencies in mental and physical develop-
ment, reflect additional roles of the CSA and CSB proteins in
the removal of oxidative damage. By demonstrating that the
trp361cys change in the CSA protein results in reduced cell
survival after UV but not after oxidative stress, the present
study also suggests that the roles of the CSA protein in the
removal of UV-induced damage and oxidative lesions may be
Materials and Methods
See SI Text for detailed procedures.
Cells. Dermal fibroblasts from patient UVSS1VI were cultured from a skin
biopsy taken from the right unexposed buttock at the age of 9 years. Primary
fibroblasts were from normal donors (GM00038, C198VI, C405VI, and C3PV);
CS-A donors [CS3BE (GM01856, Coriell Cell Repository, Camden, NJ), CS6PV,
and CS7PV]; CS-B donors [CS1AN (GM00739, Coriell Cell Repository), CS177VI,
of A. Lehmann, University of Sussex, Sussex, U.K. The SV40-transformed
fibroblast strains were from the Coriell Cell Repository (CS-A CS3BE.S3.G1),
graciously provided by the late M. Yamaizumi, Kumamoto University, Kum-
amoto, Japan (UVSS Kps3SV13.3), or generated for this study (WT C405VI-SV,
UVSS1VI-SV) as described (37). Cells were grown in minimal essential medium
(Sigma) or HAM F10 medium (Cambrex) with 10% FCS (Euroclone) and anti-
biotics at 5% CO2, 37 °C.
Chemicals. Potassium bromate (Sigma/Aldrich) stock solution (0.5 M) in PBS
was stored at room temperature and warmed to 37 °C to dissolve before use.
Menadione (Sigma/Aldrich) stock solutions (100 mM) in water were stored at
4 °C protected from light.3H-thymidine (NET-027X; 1.0 mCi/ml, specific activ-
ity 20 Ci/mmol) and3H-uridine (NET-174; 1.0 mCi/ml, specific activity 22.6
Ci/mmol) were from PerkinElmer.
Plasmid Preparation and Transfection of SV40-Transformed CS3BE Cells. Full-
length CSA cDNA from UVSS1VI cells was amplified by PCR using Pfu DNA
polymerase by standard procedures. The identity of the CSA cDNA was con-
firmed by DNA sequencing. SV40-CS3BE cells were transfected with the
pEGFP-CSAtrp361cys construct using Lipofectamine (Invitrogen) according to
the manufacturer’s instructions.
DNA Repair Assays. Responses to UV irradiation in primary fibroblasts were
evaluated by unscheduled DNA synthesis (UDS) and RRS as described (38–41).
Cell survival after UVC irradiation was carried out as described (12). Cell cycle
analysis by FACS after UVC irradiation and determination of cell survival after
UV, KBrO3or menadione treatment were determined by standard assays.
Characterization of the Gene Responsible for the Disease. Complementation
analysis was performed by measuring RRS in hybrids obtained by fusing the
patient’s cells with CS reference strains as described (41).
with plasmids expressing the normal or mutated (trp361cys) CSA protein
one Japanese patient
truncated products of
different length (34-103 aa)
pair of siblings*1
two unrelated cases*1,2
pair of siblings*2
pair of siblings*1,2
mutations found in 20 patients with CS, 8 of which are affected by the
classical form of CS (code in black), and 3 by the severe form of CS (code in
black bold). The clinical form of CS is not reported in the remaining 9 cases
(code in gray). The diagram shows the CSA protein with the 7 WD repeats
(black boxes). The amino acid changes are shown boxed, with the change
in black on white. The numbers 1 and 2 after the patient code denote the
different alleles. The change on the second CSA allele of the patient CS3BE
refers to our unpublished observations; the mutation reported in Ridley et
al. (23) is present on the genomic DNA and at the transcript level results in
the deletion of exon 5 (c. 400?481del). The 8 Brazilian patients studied by
Bertola et al. (16) are marked by*. Mutation nomenclature follows the
format indicated at www.hgvs.org/mutnomen and refers to the cDNA
sequence NM?000082.3 and protein sequence NP?000073.1. For cDNA num-
bering, ?1 corresponds to the A of the ATG translation initiation codon in
the reference sequence. The initiation codon is codon 1.
CSA protein and inactivating amino acid changes caused by the
Nardo et al. PNAS ?
April 14, 2009 ?
vol. 106 ?
no. 15 ?
tagged with EGFP was assessed by measuring RRS after UV irradiation as Download full-text
detailed in SI Text.
Molecular Analysis of the CSA Gene. Extraction of total RNA with RNeasy
(Qiagen) and reverse transcription using Moloney murine leukemia virus
reverse transcriptase (Promega) were carried out according to the manufac-
SI Text. Gel-purified PCR products were directly sequenced with the primer AS2.
ACKNOWLEDGMENTS. We thank members of the laboratory of Dr. J. C.
Weill (University of Paris V, Paris) for sequencing of the POL eta and
iota genes in the UVSS1VI cells and Mrs. D. Pham (Institut Gustave Roussy,
Villejuif, France) for the UDS and RRS analysis. This work was supported by
European Community Contract LSHM-CT-2005-512117, grants from the
Associazione Italiana per la Ricerca sul Cancro, the Fondazione Cariplo,
and the Istituto Superiore Sanita `-Programma Malattie Rare (to M.S.),
National Cancer Institute Grant CA91456 (to P.C.H.), and grants from
the Agence Nationale de la Recherche and Ligue Contre le Cancer
(Paris) and Association de Recherche sur le Cancer (Villejuif, France) (to
1. Hanawalt P, Spivak G (2008) Transcription-coupled DNA repair: Two decades of
progress and surprises. Nat Rev Mol Cell Biol 9:958–970.
2. Sarasin A, Stary A (2007) New insights for understanding the transcription-coupled
repair pathway. DNA Repair 6:265–269.
3. Stefanini M, Kraemer KHK (2008) Xeroderma pigmentosum. Neurocutaneous Dis-
eases, eds Ruggieri M, Pascual-Castroviejo I, Di Rocco C (Springer, NewYork), pp
4. Lehmann AR (2003) DNA repair-deficient diseases, xeroderma pigmentosum, Cock-
ayne syndrome, and trichothiodystrophy. Biochimie 85:1101–1111.
showing biochemical characteristics of Cockayne syndrome without typical clinical
manifestations. Mutat Res 314:233–248.
J Invest Dermatol 77:256–263.
7. Spivak G, et al. (2002) Ultraviolet-sensitive syndrome cells are defective in transcrip-
tion-coupled repair of cyclobutane pyrimidine dimers. DNA Repair 1:629–643.
8. Spivak G (2005) UV-sensitive syndrome. Mutat Res 577:162–169.
9. Horibata K, et al. (2004) Complete absence of Cockayne syndrome group B gene
product gives rise to UV-sensitive syndrome but not Cockayne syndrome. Proc Natl
Acad Sci USA 101:15410–15415.
10. Laugel V, et al. (2008) Deletion of 5? sequences of the CSB gene provides insight into
the pathophysiology of Cockayne syndrome. Eur J Hum Genet 16:320–327.
11. Hashimoto S, et al. (2008) Adult-onset neurological degeneration in a patient with
cockayne syndrome and a null mutation in the CSB gene. J Invest Dermatol 128:1597–
12. Broughton BC, et al. (2002) Molecular analysis of mutations in DNA polymerase eta in
xeroderma pigmentosum-variant patients. Proc Natl Acad Sci USA 99:815–820.
13. Botta E, et al. (2002) Reduced level of the repair/transcription factor TFIIH in tricho-
thiodystrophy. Hum Mol Genet 11:2919–2928.
binding protein complex and mutations in DDB2 which reveal the functional domains
of its p48 product. Hum Mol Genet 12:1507–1522.
15. D’Errico M, et al. (2007) The role of CSA in the response to oxidative DNA damage in
human cells. Oncogene 26:4336–4343.
16. Bertola DR, et al. (2006) Cockayne syndrome type A: Novel mutations in eight typical
patients. J Hum Genet 51:701–705.
17. Cao H, Williams C, Carter M, Hegele RA (2004) CKN1 (MIM 216400): Mutations in
18. Henning KA, et al. (1995) The Cockayne syndrome group A gene encodes a WD repeat
protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell
19. Kleppa L, Kanavin ØJ, Klungland A, Strømme P (2007) A novel splice site mutation in
the Cockayne syndrome group A gene in two siblings with Cockayne syndrome.
20. Komatsu A, Suzuki S, Inagaki T, Yamashita K, Hashizume K (2004) A kindred with
Cockayne syndrome caused by multiple splicing variants of the CSA gene. Am J Med
Genet A 128:67–71.
21. McDaniel LD, Legerski R, Lehmann AR, Friedberg EC, Schultz RA (1997) Confirmation
22. Ren Y, et al. (2003) Three novel mutations responsible for Cockayne syndrome group
A. Genes Genet Syst 78:93–102.
23. Ridley AJ, Colley J, Wynford-Thomas D, Jones CJ (2005) Characterization of novel
mutations in Cockayne syndrome type A and xeroderma pigmentosum group C
subjects. J Hum Genet 50:151–154.
24. Zhou H-X, Wang G (2001) Predicted structures of two proteins involved in human
diseases. Cell Biochem Biophys 35:35–47.
25. Groisman R, et al. (2003) The ubiquitin ligase activity in the DDB2 and CSA complexes
is differentially regulated by the COP9 signalosome in response to DNA damage. Cell
26. Saijo M, et al. (2007) Functional TFIIH is required for UV-induced translocation of CSA
to the nuclear matrix. Mol Cell Biol 27:2538–2547.
27. Kamiuchi S, et al. (2002) Translocation of Cockayne syndrome group A protein to the
Sci USA 99:201–206.
28. Fousteri M, Vermeulen W, van Zeeland AA, Mullenders LH (2006) Cockayne syndrome
A and B proteins differentially regulate recruitment of chromatin remodeling and
repair factors to stalled RNA polymerase II in vivo. Mol Cell 23:471–482.
29. Fousteri M, Mullenders LH (2008) Transcription-coupled nucleotide excision repair
in mammalian cells: Molecular mechanisms and biological effects. Cell Res
30. Laine ´ JP,EglyJM(2006)Whentranscriptionandrepairmeet:Acomplexsystem.Trends
31. Groisman R, et al. (2006) CSA-dependent degradation of CSB by the ubiquitin-
proteasome pathway establishes a link between complementation factors of the
Cockayne syndrome. Genes Dev 20:1429–1434.
32. Bohr VA, Ottersen OP, Tønjum T (2007) Genome instability and DNA repair in brain,
ageing and neurological disease. Neuroscience 145:1183–1186.
33. Kyng KJ, Bohr VA (2005) Gene expression and DNA repair in progeroid syndromes and
human aging. Ageing Res Rev 4:579–602.
34. Gorgels TG, et al. (2007) Retinal degeneration and ionizing radiation hypersensitivity
in a mouse model for Cockayne syndrome. Mol Cell Biol 27:1433–1441.
35. Jin J, Arias EE, Chen J, Harper JW, Walter JC (2006) A family of diverse Cul4-Ddb1-
interacting proteins includes Cdt2, which is required for S phase destruction of the
replication factor Cdt1. Mol Cell 23:706–721.
36. Spivak G, Hanawalt PC (2006) Host cell reactivation of plasmids containing oxidative
DNA lesions is defective in Cockayne syndrome but normal in UV-sensitive syndrome
fibroblasts. DNA Repair 5:13–22.
37. Keriel A, Stary A, Sarasin A, Rochette-Egly C, Egly JM (2002) XPD mutations prevent
TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RAR?.
38. Pasquier L, et al. (2006) Wide clinical variability among 13 new Cockayne syndrome
cases confirmed by biochemical assays. Arch Dis Child 91:178–182.
39. Sarasin A, et al. (1992) Prenatal diagnosis in a subset of trichothiodystrophy patients
defective in DNA repair. Br J Dermatol 127:485–491.
40. Stefanini M, et al. (1992) DNA repair investigations in nine Italian patients affected by
trichothiodystrophy. Mutat Res 273:119–125.
41. Stefanini M, Fawcett H, Botta E, Nardo T, Lehmann AR (1996) Genetic analysis of UV
hypersensitivity in twenty-two patients with Cockayne syndrome. Hum Genet 97:418–
www.pnas.org?cgi?doi?10.1073?pnas.0902113106 Nardo et al.